Correlation Between Virax Biolabs and Biodexa Pharmaceticals
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Biodexa Pharmaceticals, you can compare the effects of market volatilities on Virax Biolabs and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Biodexa Pharmaceticals.
Diversification Opportunities for Virax Biolabs and Biodexa Pharmaceticals
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Virax and Biodexa is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Biodexa Pharmaceticals go up and down completely randomly.
Pair Corralation between Virax Biolabs and Biodexa Pharmaceticals
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.41 times more return on investment than Biodexa Pharmaceticals. However, Virax Biolabs is 1.41 times more volatile than Biodexa Pharmaceticals. It trades about 0.02 of its potential returns per unit of risk. Biodexa Pharmaceticals is currently generating about -0.11 per unit of risk. If you would invest 195.00 in Virax Biolabs Group on December 1, 2024 and sell it today you would lose (28.00) from holding Virax Biolabs Group or give up 14.36% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Virax Biolabs Group vs. Biodexa Pharmaceticals
Performance |
Timeline |
Virax Biolabs Group |
Biodexa Pharmaceticals |
Virax Biolabs and Biodexa Pharmaceticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Virax Biolabs and Biodexa Pharmaceticals
The main advantage of trading using opposite Virax Biolabs and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Cardio Diagnostics Holdings |
Biodexa Pharmaceticals vs. Volaris | Biodexa Pharmaceticals vs. Keurig Dr Pepper | Biodexa Pharmaceticals vs. International Consolidated Airlines | Biodexa Pharmaceticals vs. Willamette Valley Vineyards |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |